Splincuf
سبلينكوف
Oral liquid antibacterial and mucolytic combination. Each 1 ml contains Lincomycin HCl 50 mg (eq. to 45.9 mg base) + Spectinomycin Sulfate 100 mg (eq. to 77.2 mg base) + Bromhexine HCl 2.5 mg (eq. to 2.3 mg base). Indicated for CRD caused by Mycoplasma and associated arthritis.
Dosage Form
N/A
Product Type
Pharmaceutical
Manufacturer
Package
N/A
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Poultry | 200 ml / tonne body weight daily in drinking water for 3-5 consecutive days | oral | 3-5 days |
Withdrawal Periods
No withdrawal information available.
Indications
-
Treatment of chronic respiratory disease (CRD) caused by Mycoplasma spp., and associated infectious arthritis in poultry.
علاج أمراض الجهاز التنفسي المزمنة (CRD) والتهاب الأكياس الهوائية الناتجة عن الميكوبلازما، والتهاب المفاصل المعدي المصاحب لها.
Contraindications
No contraindications information available.
Precautions
No precautions information available.
Side Effects
No side effects information available.
Images
Documents
No documents available.
Active Ingredients
-
Lincomycin
46 mg/ml
-
Bromhexine
2 mg/ml
-
Spectinomycin
77 mg/ml
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
ATCO Pharma for Pharmaceutical Industries
Manufacturer
Alternatives
No alternatives available.